In the News Pyrexar HT Hyperthermia


Hyperthermia products find distribution in South Korea

Salt Lake City, UT - (April14, 2015) - Pyrexar Medical, the makers of PYREXAR HT Hyperthermia-based cancer treatment systems, announced today that it has received orders for the first two units, of a multi-unit contract, for the BSD-2000 Deep Regional Hyperthermia Systems from the distribution group HanBeam Technology.

Hyperthermia is a type of cancer treatment in which tumors are exposed to elevated body temperatures, between 104˚ and 113°F. Research has shown that high temperatures can damage and kill cancer cells, usually with minimal injury to normal tissues. Hyperthermia treatment has achieved high clinical response when combined with radiotherapy in the treatment of cancer. “We are very please to have HanBeam Technology as a distribution partner” says Mark Falkowski, CEO. “HanBeam has a solid reputation as a radiation solutions provider in the Korean peninsula”.

HanBeam Technology Co., Ltd is known for installing the world’s first single-room proton therapy system and the world’s first View Ray system combining MRI, radiation cancer treatment, Intraoperative Radiation Therapy (IORT) and the BSD-2000 Hyperthermia system capable of thermal cancer treatment. The company is supplying and managing cutting-edge cancer treatment equipment to South Korea and beyond. Building on medical equipment expertise and experiences, the company has spearheaded the adoption of advanced medical equipment to the country.

For the past decade, the company contributed to the use of enhanced robotic radio surgery by providing Cyberknife to major Korean cancer treatment centers and university hospitals, improving patient care in the hospital environment

Multi-center clinical trials in the US, Europe and Asia over the past 30 years document dramatic improvement in survival rates when PYREXAR HT is combined with radiotherapy in the treatment of chest wall recurrences after breast cancer, locally advanced cervical cancer, high risk soft tissue sarcoma, melanoma and other malignancies.
Pyrexar Medical is based in Salt Lake City, UT, USA. For more information please visit our web page at:

Pyrexar Medical Media Contact:
Drew Wilkens
VP of Digital Marketing
This email address is being protected from spambots. You need JavaScript enabled to view it.

News Archive

  • PYREXAR Medical Acquires Hyperthermia Assets of BSD Medical +

    Promising Cancer Treatment Technology Now Under New Leadership Salt Lake Read More
  • Pyrexar Medical closes deal with HanBeam Technology +

    Hyperthermia products find distribution in South Korea Salt Lake City, Read More
  • Pyrexar Chief Scientist Goes to China +

    PYREXAR HT Hyperthermia products find distribution with Orientech SALT LAKE Read More
  • Pyrexar Medical expands Hyperthermia to Central Asia +

    PYREXAR HT Hyperthermia products find distribution with ORB Corporation SALT Read More
  • Pyrexar brings the Fight Against Cancer to South Korea +

    Pyrexar receives final authorization to sell Thermal Therapy devices in Read More
  • 1
  • 2
  • 3

Contact Info

We are pleased to hear from you. If we can help you with Pyrexar HT products, Clinical Studies or the Advancement of Hyperthermia. We would love to hear what you have to say.




1825 West Research Way, Ste E
Salt Lake City, UT 84119, USA

Spread the word about Hyperthermia.